Personalized Dosing of Cyclophosphamide in theTotal Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Personalized Dosing of Cyclophosphamide in theTotal Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics Vol. 85; no. 6; pp. 615 - 622
Main Authors: MCCUNE, J. S, BATCHELDER, A, GUTHRIE, K. A, WITHERSPOON, R, APPELBAUM, F. R, PHILLIPS, B, VICINI, P, SALINGER, D. H, MCDONALD, G. B
Format: Journal Article
Language:English
Published: Basingstoke Nature Publishing Group 2009
Subjects:
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Antineoplastic agent
Human
Patient
Malignant hemopathy
Posology
Alkylating agent
Oxazaphosphinane derivatives
Cyclophosphamide
Nitrogen mustard
Phase II trial
Irradiation
Conditioning
Cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0009-9236
1532-6535